• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗癌药物的增殖依赖性细胞毒性:综述

Proliferation-dependent cytotoxicity of anticancer agents: a review.

作者信息

Valeriote F, van Putten L

出版信息

Cancer Res. 1975 Oct;35(10):2619-30.

PMID:1098765
Abstract

One of the factors of importance in determining the killing of mammalian cells following exposure to a variety of anticancer agents is the proliferative state of the cell population. Generally, proliferating cells are much more sensitive to anticancer agents than are nonproliferating cells. In this review, the cellular aspects of this differential sensitivity are discussed with the hemopoietic stem cell population and tissue culture cells as the focus for the analysis. This phenomenon is not only of concern to the cell biologist but also has implications with regard to scheduling of anticancer agents against human tumors.

摘要

在确定哺乳动物细胞暴露于各种抗癌剂后被杀伤的重要因素之一是细胞群体的增殖状态。一般来说,增殖细胞比非增殖细胞对抗癌剂敏感得多。在这篇综述中,以造血干细胞群体和组织培养细胞为分析重点,讨论了这种差异敏感性的细胞方面。这种现象不仅是细胞生物学家所关注的,而且对抗癌剂治疗人类肿瘤的用药安排也有影响。

相似文献

1
Proliferation-dependent cytotoxicity of anticancer agents: a review.抗癌药物的增殖依赖性细胞毒性:综述
Cancer Res. 1975 Oct;35(10):2619-30.
2
The role of cell kinetics in cancer chemotherapy.细胞动力学在癌症化疗中的作用。
Semin Oncol. 1977 Jun;4(2):217-26.
3
Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells.二十种抗肿瘤药物对增殖和非增殖人肿瘤细胞的杀伤效果差异
Cancer Res. 1981 Jun;41(6):2328-33.
4
An anticancer drug-sensitive murine erythroleukemia clone: implications for the mechanism of action of antineoplastic drugs.一种对抗癌药物敏感的小鼠红白血病克隆:对抗肿瘤药物作用机制的启示。
Cancer Res. 1993 Apr 15;53(8):1877-82.
5
Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents.新型拓扑异构酶I和II双重抑制剂F 11782与其他抗癌药物联合使用的协同效应。
Cancer Chemother Pharmacol. 2002 Jun;49(6):479-86. doi: 10.1007/s00280-002-0451-5. Epub 2002 Apr 6.
6
Gamma-ray-induced cell killing and chromosome abnormalities in the bone marrow of p53-deficient mice.γ射线诱导p53基因缺陷小鼠骨髓细胞死亡及染色体异常。
Radiat Res. 1996 Sep;146(3):259-66.
7
Differentiation and proliferative kinetics of hemopoietic stem cells in culture.培养条件下造血干细胞的分化与增殖动力学
Prog Clin Biol Res. 1984;148:35-43.
8
Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors.芦荟大黄素是一种新型抗癌剂,对神经外胚层肿瘤具有选择性活性。
Cancer Res. 2000 Jun 1;60(11):2800-4.
9
Differential effects of cytotoxic agents on hematopoietic progenitors.细胞毒性药物对造血祖细胞的不同作用。
Cancer Res. 1981 Jun;41(6):2338-42.
10
Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells.增殖依赖性拓扑异构酶II含量作为人、小鼠和中国仓鼠卵巢细胞中抗肿瘤药物作用的决定因素。
Cancer Res. 1987 Aug 1;47(15):3973-9.

引用本文的文献

1
Recurring cycles of deprivation of serum and migration in confined spaces augments ganglioside SSEA-4 expression, boosting clonogenicity and cisplatin resistance in TNBC cell line.血清剥夺和在受限空间迁移的反复循环会增强神经节苷脂SSEA-4的表达,提高三阴性乳腺癌细胞系的克隆形成能力和顺铂耐药性。
Sci Rep. 2025 May 14;15(1):16738. doi: 10.1038/s41598-025-99828-6.
2
Conventional chemotherapy: millions of cures, unresolved therapeutic index.传统化疗:数百万次治愈,未解决的治疗指数。
Nat Rev Cancer. 2025 Mar;25(3):209-218. doi: 10.1038/s41568-024-00778-4. Epub 2024 Dec 16.
3
A Platform of Patient-Derived Microtumors Identifies Individual Treatment Responses and Therapeutic Vulnerabilities in Ovarian Cancer.
一个源自患者的微肿瘤平台可识别卵巢癌的个体治疗反应和治疗易损性。
Cancers (Basel). 2022 Jun 12;14(12):2895. doi: 10.3390/cancers14122895.
4
How translational modeling in oncology needs to get the mechanism just right.肿瘤学中的转化模型需要恰到好处地把握机制。
Clin Transl Sci. 2022 Mar;15(3):588-600. doi: 10.1111/cts.13183. Epub 2021 Nov 12.
5
Regulation of Inflammatory and Proliferative Pathways by Fotemustine and Dexamethasone in Endometriosis.氟尿嘧啶和地塞米松对子宫内膜异位症中炎症和增殖途径的调节。
Int J Mol Sci. 2021 Jun 1;22(11):5998. doi: 10.3390/ijms22115998.
6
Artesunate Affects T Antigen Expression and Survival of Virus-Positive Merkel Cell Carcinoma.青蒿琥酯影响病毒阳性默克尔细胞癌的T抗原表达及生存。
Cancers (Basel). 2020 Apr 9;12(4):919. doi: 10.3390/cancers12040919.
7
The effects of proliferation status and cell cycle phase on the responses of single cells to chemotherapy.细胞增殖状态和细胞周期对化疗药物作用于单细胞反应的影响。
Mol Biol Cell. 2020 Apr 1;31(8):845-857. doi: 10.1091/mbc.E19-09-0515. Epub 2020 Feb 12.
8
ATR kinase inhibition sensitizes quiescent human cells to the lethal effects of cisplatin but increases mutagenesis.ATR 激酶抑制使静止的人细胞对顺铂的致死作用敏感,但增加了突变率。
Mutat Res. 2019 Nov;816-818:111678. doi: 10.1016/j.mrfmmm.2019.111678. Epub 2019 Sep 17.
9
Ethyl 3-oxo-2-(2,5-dioxopyrrolidin-3-yl)butanoate Derivatives: Anthelmintic and Cytotoxic Potentials, Antimicrobial, and Docking Studies.3-氧代-2-(2,5-二氧代吡咯烷-3-基)丁酸乙酯衍生物:驱虫和细胞毒性潜力、抗菌及对接研究
Front Chem. 2017 Dec 12;5:119. doi: 10.3389/fchem.2017.00119. eCollection 2017.
10
LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivity.LGR5 的表达受早期结直肠腺瘤中 EGF 的调控,并控制 EGFR 抑制剂的敏感性。
Br J Cancer. 2018 Feb 20;118(4):558-565. doi: 10.1038/bjc.2017.412. Epub 2017 Nov 16.